tiprankstipranks
Trending News
More News >
Trinity Biotech Plc (TRIB)
NASDAQ:TRIB
US Market

Trinity Biotech (TRIB) Financial Statements

Compare
374 Followers

Trinity Biotech Financial Overview

Trinity Biotech's market cap is currently $13.67M. The company's EPS TTM is $-0.274; its P/E ratio is -0.30; Trinity Biotech is scheduled to report earnings on December 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 61.55M$ 56.83M$ 62.52M$ 81.15M$ 101.98M
Gross Profit$ 21.44M$ 19.45M$ 22.05M$ 33.45M$ 48.58M
Operating Income$ -21.16M$ -27.05M$ -15.27M$ 3.94M$ 82.00K
EBITDA$ -16.91M$ -24.10M$ -16.71M$ 10.59M$ 3.19M
Net Income$ -31.79M$ -24.02M$ -41.00M$ 875.00K$ -6.39M
Balance Sheet
Cash & Short-Term Investments$ 5.17M$ 3.69M$ 6.58M$ 25.91M$ 27.33M
Total Assets$ 103.29M$ 59.44M$ 92.10M$ 118.89M$ 130.40M
Total Debt$ 100.76M$ 67.43M$ 72.20M$ 99.16M$ 104.34M
Net Debt$ 95.60M$ 63.74M$ 51.68M$ 73.25M$ 77.01M
Total Liabilities$ 138.47M$ 83.38M$ 94.28M$ 119.21M$ 132.62M
Stockholders' Equity$ -35.18M$ -23.95M$ -2.18M$ -319.00K$ -2.22M
Cash Flow
Free Cash Flow$ -14.26M$ -12.36M$ -6.90M$ 4.55M$ 13.56M
Operating Cash Flow$ -4.19M$ -11.56M$ -921.00K$ 13.24M$ 23.75M
Investing Cash Flow$ -22.97M$ 24.76M$ -5.98M$ -8.69M$ -10.20M
Financing Cash Flow$ 28.81M$ -16.04M$ -12.32M$ -6.02M$ -2.72M
Currency in USD

Trinity Biotech Earnings and Revenue History

Trinity Biotech Debt to Assets

Trinity Biotech Cash Flow

Trinity Biotech Forecast EPS vs Actual EPS